Data / Form D filings / VACCINEX, INC.
VACCINEX, INC.: Form D filings
VACCINEX, INC., a pharmaceuticals company in Rochester, NY, filed 10 Form D notices with the SEC between 2017 and 2024. The latest, on September 27, 2024, reports $200,155 sold of a $9.2 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1895 Mount Hope Avenue, Rochester, NY, 14620
- Phone
- (585) 271-2700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1205922
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | New notice | $9,224,732 | $200,155 | $9,024,577 | 8 | Sep 18, 2024 | sec.gov |
| Apr 12, 2024 | New notice | $2,462,090 | $1,240,737 | $1,221,353 | 3 | Mar 28, 2024 | sec.gov |
| Apr 12, 2024 | New notice | $3,499,995 | $1,750,000 | $1,749,995 | 1 | Mar 29, 2024 | sec.gov |
| Apr 12, 2024 | New notice | $1,474,520 | $0 | $1,474,520 | 4 | Mar 28, 2024 | sec.gov |
| Sep 16, 2020 | New notice | $2,000,000 | $2,000,000 | 1 | Sep 1, 2020 | sec.gov | |
| Aug 11, 2020 | New notice | $8,000,000 | $8,000,000 | 1 | Aug 3, 2020 | sec.gov | |
| Jul 15, 2020 | New notice | $4,000,000 | $4,000,000 | 1 | Jul 10, 2020 | sec.gov | |
| Feb 3, 2020 | New notice | $7,474,986 | $7,474,986 | 5 | Jan 23, 2020 | sec.gov | |
| Aug 14, 2019 | New notice | $13,799,915 | $13,799,915 | 5 | Jul 30, 2019 | sec.gov | |
| Jul 7, 2017 | New notice | $18,200,000 | $6,000,000 | $12,200,000 | 1 | May 31, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jacob B. Frieberg | Director | |
| Gerald E. Van Strydonck | Director | |
| Albert D. Friedberg | Director | |
| Maurice S. Zauderer, Ph.D. | Director, Executive Officer | |
| Elizabeth S. Evans | Executive Officer | |
| Barbara S. Yanni | Director | |
| Ernest S. Smith Ph.D. | Executive Officer | |
| Jill S. Sanchez | Executive Officer | |
| Bala S. Manian Ph.D. | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Sep 23, 2024 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what VACCINEX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.